By contrast, HCT/0.5-mono-mIL12 with the highest affinity for HER2 showed the weakest antitumor activity, with a 0% (n = 0/14) rate of tumor-free survival in the mice (Supplementary Figure 3). Here, ERBB2 is linked to neoplasm.